![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » SMITH & NEPHEW AND Q-MED ENTER INTO STRATEGIC ALLIANCE IN OSTEOARTHRITIS TREATMENT
SMITH & NEPHEW AND Q-MED ENTER INTO STRATEGIC ALLIANCE IN OSTEOARTHRITIS TREATMENT
June 28, 2006
Smith & Nephew Orthopaedics Trauma & Clinical Therapies and Q-MED AB today announced that they have formed a strategic alliance to develop and commercialize Q-MED's proprietary technology for the production of stabilized non-animal hyaluronic acid, NASHA for orthopedic uses.
Drug Newswire
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct